Feeling Dismissed About Your Perimenopause Symptoms? Here's Where To Actually Find Good Care.
Welcome to the Perimenopause Playbook—your guide to navigating the most overlooked and misunderstood phase of the menopausal transition. Read the rest of the stories, from how to get a diagnosis to treatment options to where to actually find good care, here.
The key to optimizing your health in perimenopause and beyond is to find a Menopause Society certified practitioner (MSCP) who has received additional training in menopause care, won't dismiss your symptoms, and offers you research-backed hormonal and non-hormonal solutions. Start with these resources, available in all 50 states plus D.C., below.
Alloy provides virtual support and treatment of common menopause symptoms from menopause-trained doctors. The telehealth platform doesn't take insurance, but it does accept FSA/HSA payment options.
Midi Health is a virtual care clinic focused on hormone health, peri- and menopause management, longevity, and aging well. Midi takes insurance, as well as HSA/FSA payment options.
Similar to Alloy and Midi, Evernow is an online platform that offers comprehensive menopause care. Evernow takes insurance for all video visits. If you choose to go the membership route, though, those are only HSA/FSA-eligible.
If telehealth isn't your thing, The Menopause Society has a 'Find a Healthcare Practitioner' tab, where you can search for certified menopause practitioners in your state.
This story appears in the Summer 2025 issue of Women's Health.
You Might Also Like
Jennifer Garner Swears By This Retinol Eye Cream
These New Kicks Will Help You Smash Your Cross-Training Goals
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
15 minutes ago
- Bloomberg
Stock Movers: Alphabet, Las Vegas Sands, UnitedHealth
On this episode of Stock Movers: - Alphabet (GOOGL) shares rise after the company said demand for artificial intelligence products boosted quarterly sales, and now requires an extreme increase in capital spending — heightening pressure on the company to justify the cost of keeping up in the AI race. - Las Vegas Sands (LVS) shares climb after the casino and resorts operator reported adjusted earnings per share for the second quarter that beat the average analyst estimate. Analysts attribute the beat to a solid performance in Singapore offsetting weakness in Macau. - UnitedHealth (UNH) shares fall. UnitedHealth is responding to criminal and civil requests from the US Department of Justice about its Medicare practices, the company said, and has "full confidence" in its practices.
WIRED
15 minutes ago
- WIRED
An Inventor Is Injecting Bleach Into Cancerous Tumors—and Wants to Bring the Treatment to the US
Xuewu Liu, a Chinese inventor who has no medical training or credentials of any kind, is charging cancer patients $20,000 for access to an AI-driven but entirely unproven treatment that includes injecting a highly concentrated dose of chlorine dioxide, a toxic bleach solution, directly into cancerous tumors. One patient tells WIRED her tumor has grown faster since the procedure and that she suspects it may have caused her cancer to spread—a claim Liu disputes—while experts allege his marketing of the treatment has likely put him on the wrong side of US regulations. Nonetheless, while Liu currently only offers the treatment informally in China and at a German clinic, he is now working with a Texas-based former pharmaceutical executive to bring his treatment to America. They believe that the appointment of Robert F. Kennedy Jr. as health secretary will help 'open doors' to get the untested treatment—in which at least one clinic in California appears to have interest—approved in the US. Kennedy's Make America Healthy Again (MAHA) movement is embracing alternative medicines and the idea of giving patients the freedom to try unproven treatments. While the health secretary did not respond to a request for comment about Liu's treatment, he did mention chlorine dioxide when questioned about President Donald Trump's Operation Warp Speed during his Senate confirmation hearing in February, and the Food and Drug Administration recently removed a warning about substance from its website. The agency says the removal was part of a routine process of archiving old pages on its site, but it has had the effect of emboldening the bleacher community. 'Without the FDA's heavy-handed warnings, it's likely my therapy would have been accepted for trials years earlier, with institutional partnerships and investor support,' Liu tells WIRED. He says he wrote to Kennedy earlier this year urging him to conduct more research on chlorine dioxide. 'This quiet removal won't immediately change everything, but it opens a door. If mainstream media reports on this shift, I believe it will unlock a new wave of serious [chlorine dioxide] research.' For decades, pseudoscience grifters have peddled chlorine dioxide solutions—sold under a variety of names, such as Miracle Mineral Solution—and despite warnings and prosecutions, have continued to claim the toxic substance is a 'cure' for everything from HIV to Covid-19 to autism. There is no credible evidence to back up any of these claims, which critics have long labeled as nothing more than a grift. The treatments typically involve drinking liquid chlorine dioxide on a regular basis, using solutions with concentrations of chlorine dioxide of around 3,000 parts per million (ppm), which is diluted further in water. Liu's treatment, however, involves a much higher concentration of chlorine dioxide—injections of several milliliters of 20,000ppm—and, rather than drinking it, patients have it injected directly into their tumors. Liu claims he has injected himself with the solution over 50 times and suffered no side effects. 'This personal data point encouraged me to continue research,' he says.
Bloomberg
15 minutes ago
- Bloomberg
C3.ai CEO Tom Siebel to Seek Successor Due to Health Concerns
Software company Inc. is looking for a new chief executive officer after Tom Siebel said he intends to step aside due to health concerns. 'After being diagnosed with an autoimmune disease in early 2025, I have experienced significant visual impairment,' Siebel said in a statement Thursday. He will remain executive chairman once the company's board appoints a successor, he added.
